MENU
+Compare
ABVX
Stock ticker: NASDAQ
AS OF
Oct 27, 04:59 PM (EDT)
Price
$94.94
Change
+$4.18 (+4.61%)
Capitalization
7.16B

ABVX Abivax SA Forecast, Technical & Fundamental Analysis

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases... Show more

ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ABVX with price predictions
Oct 24, 2025

ABVX sees MACD Histogram just turned negative

ABVX saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 21, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 25 instances where the indicator turned negative. In of the 25 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for ABVX moved out of overbought territory on October 16, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 12 similar instances where the indicator moved out of overbought territory. In of the 12 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on October 23, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ABVX as a result. In of 31 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABVX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ABVX broke above its upper Bollinger Band on October 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ABVX advanced for three days, in of 122 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 68 cases where ABVX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ABVX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.749) is normal, around the industry mean (24.410). P/E Ratio (0.000) is within average values for comparable stocks, (54.672). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.161). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (192.308) is also within normal values, averaging (355.200).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABVX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ABVX is expected to report earnings to fall 50.72% to -68 cents per share on December 15

Abivax SA ABVX Stock Earnings Reports
Q3'25
Est.
$-0.68
Q2'25
Missed
by $0.70
Q1'25
Missed
by $0.29
Q4'24
Beat
by $0.50
Q3'24
Beat
by $0.07
The last earnings report on September 08 showed earnings per share of -137 cents, missing the estimate of -68 cents. With 852.63K shares outstanding, the current market capitalization sits at 7.16B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
7-11 boulevard Haussmann
Phone
+33 153830963
Employees
24
Web
https://www.abivax.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VSCPX357.952.32
+0.65%
Vanguard Small Cap Index InstlPlus
VYCGX27.960.14
+0.50%
Voya Corporate Leaders 100 R6
WMGAX26.940.13
+0.48%
Macquarie Mid Cap Growth A
SGIDX39.030.15
+0.39%
Steward Global Equity Income Fund A
POIIX16.33N/A
N/A
Polen International Growth Institutional

ABVX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVX has been loosely correlated with NEVPF. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVX jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVX
1D Price
Change %
ABVX100%
+0.32%
NEVPF - ABVX
65%
Loosely correlated
N/A
IMNN - ABVX
58%
Loosely correlated
-1.22%
ANEB - ABVX
52%
Loosely correlated
+1.10%
CLSD - ABVX
51%
Loosely correlated
+2.63%
CGON - ABVX
38%
Loosely correlated
+4.03%
More